Rapid assessment of cardiovascular risk among users of smoking cessation drugs within the US Food and Drug Administration's Mini-Sentinel program. Article uri icon

Overview

publication date

  • May 13, 2013

Research

keywords

  • Benzazepines
  • Bupropion
  • Cardiovascular Diseases
  • Dopamine Uptake Inhibitors
  • Nicotinic Agonists
  • Product Surveillance, Postmarketing
  • Quinoxalines
  • Sentinel Surveillance
  • Smoking Cessation

Identity

Scopus Document Identifier

  • 84877736063

Digital Object Identifier (DOI)

  • 10.1001/jamainternmed.2013.3004

PubMed ID

  • 23529063

Additional Document Info

volume

  • 173

issue

  • 9